Veterinary Medicine Information website

MILBEMAX 2.5 MG/25 MG TABLETS FOR SMALL DOGS AND PUPPIES

Authorised
  • Milbemycin oxime
  • Praziquantel

Product identification

Medicine name:
MILBEMAX 2.5 MG/25 MG TABLETS FOR SMALL DOGS AND PUPPIES
Active substance:
  • Milbemycin oxime
  • Praziquantel
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Milbemycin oxime
    2.50
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    25.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AB51
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Available in:
  • Denmark
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Elanco France S.A.S
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 34567
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0135/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Czechia
  • Denmark
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (, TABLETTER)
Published on: 14/03/2026

Combined File of all Documents

English (PDF)
Published on: 7/02/2025
Updated on: 14/03/2026
Download